Private equity groups Bain and Cinven are set to launch a revised bid for German drugmaker Stada (STAGn.DE), possibly next week, people close to the matter said on Friday.

Stada’s management is now reviewing the new offer, which is at the same price as the previous 5.3 billion euro ($6 bln) bid but lowers the shareholder approval threshold to somewhere below 65 percent, the sources said.

The private equity firms’ previous offer of 66 euros a share, launched in April, secured the support of 65.52 percent of Stada’s equity but failed to go through because the threshold was 67.5 percent.

READ FULL ARTICLE HERE